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Summary.-Cells ofthe methylene dimethanesulphonate-(MDMS)-resistant Yoshida
sarcoma cell line contain a low molecular weight " resistance factor " which is
present in the culture medium of these cells and may be utilized by MDMS-sensitive
Yoshida sarcoma cells either by co-culturing the two cell lines or by culturing the
MDMS-sensitive Yoshida cells in a medium containing 20% used medium of MDMS-
resistant Yoshida cells or in the presence of dialysed medium from resistant cells.
The " resistance factor " does not inactivate the drug itself or its metabolites, and it
has no influence on the sensitivity of the cells if added after MDMS treatment.
Twenty-four hours seems to be enough time for the transfer of the resistance factor,
but its effect on whole populations decreases within 24 hours of ceasing the supply.
The relationship between these findings and the known phenomena of metabolic
co-operation are discussed.
METABOLIC co-operatioin has been
demonstrated by a number of workers
(Subak-Sharpe, Btirk and Pitts, 1969;
Van Diggelen, Van Zeeland and Simons,
1972; Fujimoto and Seigmiller, 1970;
Ashkenazi and Gartler, 1971) between
cultured cells showing a deficiency in the
enzyme HG-PRT (hypoxanthineguanine
phosphoribosyl transferase) which confers
resistance to the antimetabolite 8-azagua-
nine and wild-type cells which are sensitive
to the drug. Most of the data are consis-
tent with the idea that co-operation occurs
by cell-cell contact, but some workers
(Fujimoto and Seigmiller, 1970 and Ash-
kenazi and Gartler, 1971) have provided
additional evidence that transfer may
occur via mRNA or proteins, since
HG-PRT negative cells can reacquire the
enzymeandbecomesensitivetoazaguanine
after the addition of a 10,000 g supernate
from wild-type cells or by the addition of
conditioned media from dense wild-type
cultures (Ashkenazi and Gartler, 1971).
The above phenomenon is well docu-
mented in the case of HG-PRT, has been
observed for other phenotypes, and con-
cerns the acquisition of drug sensitivity
by resistant cells. On the other hand,
there is relatively little information about
transfer of resistance, in particular that
to alkylating agents to sensitive cells.
The only case appears to be that reported
by Ujhazy (1969) who demonstrated that
drug sensitivity of the Walker tumour
decreased after it was passaged with
Yoshida sarcoma cells that were resistant
to a nitrogen mustard derivative TS-160
Spofa. Subsequently, Ujhazy et al. (1971)
extended their observations and demon-
strated that cytoplasmic fractions from
L-asparaginase resistant Gardner lympho-
sarcomaand5-fluorouracilresistantEhrlich
ascites carcinoma could decrease the
sensitivity of sensitive cells, and that the
effect was shown even when the cell homo-
genate was added in vivo. These workers
also presented evidence to suggest that
cytoplasmic fractions of the resistant
cells were taken up by sensitive cells.
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These phenomena thus resemble closely
those attributed to metabolic co-opera-
tion, but in this case cell-cell contact
appeared to be unnecessary.
Such phenomena could be of practical
importance in tumour chenmotherapy since
they could increase the rate of develop-
ment of resistance. Experiments were
therefore designed to determine whether
metabolic co-operation could play a role
in the development of resistance of
Yoshida rat sarcoma cells to methylene
dimethanesulphonate (M1DMS).
MATERIALS ANI) METHODS
The MDMS-sensitive (YS) and MDMS-
resistant (YR) Yoshida sarcoma cell lines
were used, developed in vivo by Fox (1969)
and isolated in vitro by Fox and Fox (1971).
MDMS was prepared as described previously
(Fox and Jackson, 1965).
The cells were cultured in suspension
using Fischer's medium containing 2(0%
horse serum (HOS). Treatment was carried
out during the exponential phase (1-2 x 105
cells/ml) of proliferation of the cells using
drug dissolved in appropriate concentrations
in physiological saline and sterilized by
Millipore filtration. Plating in soft agar
and determination of survival by extra-
polation of growth curves were carried out
according to the methods used in this
laboratory as described previously (Fox and
Fox, 1971). Autoradiography was carried
out as described by Fox and Gilbert (1966).
The following experimental models were
used:
Co-culture of cells.-We have previously
demonstrated that YR cells are unable to
form colonies in soft agar (Fox and Fox,
1971). Therefore co-culture experiments
were undertaken with the expectation that
any colonies produced had a high probability
ofbeing derived from sensitive cells. MDMS-
sensitive Yoshida (YS) and MDMS-resistant
Yoshida (YR) cells were therefore mixed
with each other in various proportions,
i.e. using 10-50-75-90% YS cells and
90-50-25-10% YR cells respectively. The
cells of the 2 cell lines were cultured together
for 24 hours. Following this 24-hour period
of co-culture, the mixed cell population
was exposed for 30 minutes to a range of
doses of MDMS. The drug-containing
medium was subsequently removed by
centrifugation and the cells plated in normal
growth medium in soft agar.
2. Preparation of conditioned medium
fromn YR and YS cells.-Exponentially
growing cultures of YS and YR cells were
centrifuged and then suspended in fresh
Fischer's medium containing 20% horse
serum. After 2 days when the cell density
had reached .4 x 105/ml the medium was
removed by further centrifugation and the
supernatant was used as conditioned medium
from resistant cells (YRM) and sensitive
cells (YSM). Various concentrations (10-
100%) of YRM and YSM, diluted with
Fischer's medium containing 20% horse
serum, were used for culturing cells.
3. Dialysis of medium of exponentially
growing YR cells in the presence of YS cells.-
Since, in using the 2 methods just described,
it was possible that some contamination of
sensitive cells by resistant cells could occur,
2 ml of normal medium containing exponen-
tially growing YR cells (approximately
4 x 105 cells/ml) wiere inoculated into a
plastic dialysis bag previously sterilized by
exposure to u.v. light (18 hours at dose rate
-10 erg/see) and the bag suspended in a
bottle which contained exponentially growing
YS (20 ml 5 x 104 cells/ml) cells in normal
growth medium. After 24 hours the bag
wa.s removed, together with the YR cells,
and the YS cells were harvested and subse-
quently treated with MDMS and plated in
soft agar using normal medium.
RESULTS
C"o-culture of sensitive and resistant cells
The results of the experiments using
co-cultured cells are summarized in Fig. 1.
When the mixture of 10% YS and 90%0
YR cells was exposed to MDMS the
sensitivity of the cell mixture to MDMS
decreased considerably. Smaller effects
were seen with other mixtures of cells in
other proportions but a decrease could
still be seen in the case of the 25 : 7500
and the 50 : 500 mixtures.
The plating efficiency of the cell
mixtures was constant at 25-300° of the
estimated number of sensitive cells, which
is slightly lower than the plating efficiency
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Dose of MDMS( Cg/ml)
FIG. 1. Dose response curves for Yoshida
sensitive cells alone and for co-cultures of
various proportions of resistant and sensit-
ive cells plated in soft agar after treatment
with MDMS. Co-cultures were grown for
24 hours before treatment with MDMS and
plated in medium containing Fischer's med-
ium and 20% horse serum (HOS). Under
these conditions only sensitive cells are
capable of forming colonies in soft agar.
Results are mean of 2 experiments.
35-40°/0 obtained when sensitive cells
alone are plated. It has been previously
shown that the resistant line will not form
colonies in agar (Fox and Fox, 1971);
therefore the observed colonies are prob-
ably derived from the sensitive line,
suggesting the transfer of a " resistance
factor ". This possibility has been further
tested as follows:
In order to make sure whether both
kinds of cells are present in the population
after 24 hours, an exponentially growing
culture of YR cells was incubated in
the presence of 3HTdR (0.2 ,tCi/ml; 26
Ci/mM) for 24 hours. After this, a
50: 5000 mixture of labelled YR cells
and unlabelled YS cells was prepared and
the mixture cultured for 24 hours, and
autoradiographs were subsequently made
by the following method: After 24 hours
of co-culture in suspension the cell pellet
obtained by centrifugation (800 rev/min
for 10 minutes) was washed twice with
0*9o saline, subjected to hypertonic treat-
ment with 1% sodium citrate, then fixed
and stained with acetic orcein. Auto-
radiographs were prepared as described
by Fox and Gilbert (1966). Slides were
exposed for 7 days and then the percentage
oflabelled cells was determined by scoring
5000 cells.
The cell population contained 60% YS
cells and 4000 YR cells the proportion
which would be expected, taking into
account the very similar growth rate of
the 2 cell lines reported before (Fox and
Fox, 1971) and also found in our recent
experiments. No phagocytosis oflabelled
cell particles by unlabelled cells was
observed.
Characterization of colonies surviving
MDMS treatment after co-cultutre
If the colonies surviving MDMS treat-
ment after co-culture of sensitive and
resistant cells are truly derived from
sensitive cells then they should (a) retain
their agar colony forming ability and (b)
retain some evidence of transferred resist-
ance. The following experiment was
therefore performed:
A 1000 sensitive: 90°, resistant cell
mixture was prepared and co-cultured in
suspension for 24 hours. Aliquots of
the mixture were then plated in agar with
or without exposure to 40/tg/ml MDMS.
After incubation for 10 days, colonies
were isolated from control untreated
mixed cultures S/RC and treated mixed
cultures S/R40 and grown in suspension
until enough cells were available for
further testing. The sensitivity of these
clones, i.e. S/RC and S/R40, to MDMS
was compared with that of the original
sensitive line YS and the original resistant
line YR by the extrapolated growth curve
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FIG. 2.-Effect of MDMIS treatment on
Yoshida S 0 and Yoshida R V cells and
on control (S/RC) 0 and treated (S/R40)
A clones isolated after co-culture of 10%
sensitive and 900o resista:nt cells in the
same conditions as described in Fig. 1,
where resistant cells are unable to form
colonies in soft agar. Clones were cultured
for 7 days after isolation before retesting.
The 2 experiments were performed within
3 days of each other.
method (Fox and Fox, 1971) and by the
agar cloning technique.
The dose response curves in Fig. 2
show that the clone S/RC was more
resistant than the original sensitive line
YS and that S/R40 was more resistant
than either. S/R40 was, however, not as
resistant as the original resistant line YR.
Clones YS, S/RC and S/R40 all retained
their ability to form colonies in agar but
again no colonies were obtained when YR
cells alone were plated. Although it can
be argued from the results just presented
(Fig. I and 2) that the YR cells may be
rescued by some factor released by YS
cells which enables them to form colonies
in agar, this possibility has been dis-
counted by experiments to be described
in the next section.
Transference of resistance by conditioned
medium
In theexperiments described above it is
possible that hybrid cells are produced, or
that the effect is the result of metabolic
co-operation resulting from cell-cell con-
tact. To determine whether resistance
could be conferred in the absence of
resistant cells, we prepared conditioned
medium as described in " Methods "
from both sensitive (YSM) and resistant
(YRM) cell cultures.
Using YRM and YSM conditioned
medium, we initially determined whether
the conditioned medium itself influenced
the growth rate of YS or YR cells. The
proliferation of both YS and YR cells
cultured in 10 and 20% YRM or YSM was
measured by counting the cell numbers
on 5 subsequent days.
The cells ofeachtype ofculture showed
a proliferation rate similar to those of the
control cultures maintained in fresh normal
medium (Table I). These data also
demonstrate the similarity in growth rate
of the 2 cell lines.
YR and YS cells were then cultured
in conditioned medium for 24 hours
before treatment (5-40 /,tg/ml MDMS for
30 minutes) and then plated in soft agar.
The dose response curves for YS cells
cultured for 24 hours before treatment
in 10-100°, YRM are shown in Fig. 3.
When 20°/ YRM was used the drug sensi-
tivity decreased considerably, but at
higher or lower concentrations the condi-
tioned medium was not as efficient in
protecting the YS cells against MDMS
toxicity. As a control to these experi-
ments and the co-culture experiment
previously described, YR cells were cul-
tured for 24 hours in YSM, then plated
in soft agar and their colony forming
efficiency determined. Growth in the
presence of YSM for 24 hours did not
confer colony forming ability on the
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TABLE I.-Growth of Yoshida Sensitive and Yoshida Resistant (Cells over a 5-day Period
in Fischer's Medium Plus 20%o Horse Serum (HOS) in the Presence or Absence of 10%
or 200% YRM or YSM ConditionedMedium, Compared with their Growth in Fischer's
Medium Containing 20%; Horse Serum (HOS) Alone
Cell number/mi()l on subsequent (lays
(x 104)
Medium Cells 1 2 3 4 5
10% YSM YS 1 2.1 i 5-4 21 65
2000 YSM YS 1 2 5 6.8 23 70
10% YRM YS 1 2-0 60-( 28 80
20% YRAI YS 1 2 6 6-6 27 92
Fischer's YS 1 2 4 6 9 30 90
plus 20% HOS
10% YSM YR 1 2 4 4-8 16 52
2000/ YSM YR 1 2 0 4 4 16 70
10% YRM YR 1 2-4 5 6 18 80
20% YRAt YR 1 2 8 6 0 19 92
Fischer's YR 1 2 8 6 0 18 80
plus 20% HOS
resistant cells: no colonies
the 10 plates examined.
were seen in
Dose of MDMS(,5g/ml)
FIG. 3. Effect of MDMS on Yoshida S cells
cultured for 24 hours before treatment in the
presence of various concentrations of YRM
conditioned medium. Results are mean
of 2 experiments.
Effect of conditioned medium on the rate of
breakdown of MDMS
To determine whether there was a
factor present in the YRM which was
capable of accelerating the rate of drug
breakdown, sensitive cells were treated
with MDMS for 30 minutes in the presence
of 20% YRM. Cells were then washed
free of drug and conditioned medium
and plated in soft agar. In addition, the
effect of adding the YRM after treatment
of sensitive cells with MDMS was deter-
mined to test whether protection could
be afforded by post-treatment. Fig. 4
shows the dose response curves of the 2
experiments. There is a slight decrease
of sensitivity in the low dose range when
treatment was carried out in 20% YRM;
otherwise the curves closely resemble
the control curve. This slight decrease
appears to reflect the multicomponent
nature of the dose response curves as
seen during development of resistance
(Fig. 1 and 3), but we have no explanation
at present for their complex pattern.
Culture in YRM after treatment did not
affect the dose response curve at all.
Stability of transferred resistance
In order to obtain information about
the stability of the transferred resistance,
YS cells, cultured for 24 hours in 20%
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Fic. 4. Effect of MDMS treatment on Yosh-
ida S cells, treated or plate(d in soft agar in
the presence of20% YRAI. 0 Control YS,
x Cells plated in YRM after MDMS treat-
ment in normal medium 0 Cells exposed to
YRMI during 30-min treatment with MDMS.
YRM, were cultured for a further 24
hours in normal Fischer's medium contain-
ing 2000 horse serum before treatment
with MDMS and plating in soft agar in
normal medium.
The dose response curves shown in
Fig. 5 indicate that there is still a decrease
in sensitivity but that the cells have lost a
significant proportion of the initial trans-
ferred resistance.
Transfer of the " resistance factor " to
sensitive cells through a semi-permeable
membrane
In an approach directed at establishing
the chemical nature of the factor released
by the drug resistant cells, we incubated
YS cells under conditions in which they
were separated from YR cells by a semi-
permeable membrane as described.
The dose response curve in Fig. 6
shows a considerable decrease in sensi-
tivity of YS cells incubated for 24 hours
in the presence of YR cells. This result
5 10 20 30 40
Dose of MDMS(pg/ml)
FIG. 5. Effect ofMDMS treatment on Yosh-
ida S cells, cultured for 24 hours in 20%
YRM and after this for 24 hours in normal
medium before exposure to MDMS. 0
Control, 0 YS cells treated with YRM.
suggests that the "resistance factor"
passes through the pores of the dialysis
bag; therefore its molecular weight is
lower than 10,000. The protective effect
ofthe dialysed medium was approximately
equal to the effect observed when 40°,
or 10% conditioned medium was used for
culture of cells 24 hours before treatment.
As a control to the above, in a separate
experiment YS cells were cultured for 24
hours in the medium from inside the
dialysis bag, from which the YR cells
had been removed by centrifugation
after they had been cultured inside the
dialysis bag in the presence of sensitive
cells for 24 hours. No protective effect
of this " spent " medium was observed.
This result suggests that the " resistance
factor" diffuses through the dialysis
membrane as rapidly as it is produced,
and that it is equally rapidly absorbed by
sensitive cells ifthey are present.
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FIG. 6. Effect of MDMS treatment on Yosh-
ida S cells ctilttirecl for 24 hours in normal
growth me(lium in which a dialysis bag con-
tainirig a 2 ml culture of Yoshida R cells
(4 x 105 ml) was suspendled. *Control, i.e.
YS cells cultured in normal medium before
treatmeuit, O YS cells culture(d for 24
hours in normal medium together with YR
cells but separated from them by a semi-
permeable membrane.
DISCUSSION
The behaviour of Yoshida cells sensi-
tive to MDMS in response to exposure to
cells resistant to MDMS closely resembles
the behaviour of a number of HG-PRT-
negative mammalian cell lines when either
co-cultured with enzyme positive cells or
exposed to extracts of, or conditioned
medium from, enzyme positive cells. In
the case of transference of MDMS resist-
ance, cell-cell contact appears to be
unnecessary and the factor is apparently
transferred by a dialyzable fraction of
medium from YR cells. A loss of protec-
tion afforded by the factor graduallv
occurs when the supply of it ceases.
Similar observations have been reported
by Ashkenazi and Gartler (1971), who
suggested that either metabolic turnover
of the factor occurred or that it was
diluted out of the cells by division.
Two observations were made in the
present study in relation to the stability
of the transferred factor in sensitive
cells. Firstly, in experiments in which
colonies were isolated from mixed cultures
some degree of resistance was retained
over the 3-weekperiodrequired fortesting,
as indicated by the reduced sensitivity
shown by clones S/RC and S/R40 com-
pared with that of the original YS cell
line (Fig. 2). This finding suggests that
the factor is relatively stable. The differ-
ence in sensitivity between clone S/RC
and S/R40 suggests that there may be
some enhancement or fixation of resist-
ance due to drug selection. The degree
of acquired resistance resulting from
selection alone in the absence ofco-culture
with fully resistant cells is probably relatively small, since we have previously
shown (Szende and Fox, 1973) that at
least 3 successive exposures of YS cells
to MDMS are necessary before significant
resistance develops.
On the other hand, when sensitive
cultures were exposed to conditioned
medium YRM for 24 hours, then cultured
in normal growth medium for 24 hours
before exposure to MDMS, a significant
proportion of the protection originally
afforded by YRM was lost, cf. Fig. 5
and Fig. 3. In the case of co-culture
experiments, therefore, resistance was
apparently stable whereas when YRM was
used approximately 5000 ofthe protection
conferred was lost during a 24-hour period
of culture in normal growth medium.
Several factors may be responsible for
this difference. In the first case, clonal
isolates were made after co-culture of
sensitive and resistant cells whereas when
YRM was used whole populations were
studied. It is possible, therefore, that
either there is a much more efficient trans-
fer and retention of the factor when cell-
cell contact occurs or that the efficiency
oftransfer ofthe factor is the same in both
cases, but when whole populations are
exposed only " competent" cells take up the factor. Competent cells may repre-
sent a small fraction of the total popula-
tion, perhaps cells in a particular stage
of the cycle, and they mav divide more
slowly after absorption of the factor,
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thus reducing their proportion relative
to the total population.
The reduced effectiveness of high
concentrations of conditioned medium
may be due (a) to the presence of some
toxic metabolites from resistant cells,
as evidenced by a reduction in plating
efficiency in cultures exposed to condi-
tioned medium but no drug or (b) to the
exhaustion of some growth promoting
factors during the production of the
conditioned medium.
In conclusion, therefore, we suggest
that after the first treatment with a drug,
a small proportion ofthe whole population
survives which is resistant to this drug
either by selection or as a result of
mutation. Such cells release the proposed
" resistance factor " into the intercellular
fluid and it is then transferred to other
drug sensitive cells. Thus, at the time
of the second treatment a much higher
number of cells survive and they, in
addition to the resistance developed by
absorption of the factor, may develop
their own resistance due to further selec-
tion. In this way, resistance of the
majority of the cell population could
develop after a single treatment, as is
observed in some instances after in vivo
exposure of the Yoshida sarcoma to
MDMS (Fox, 1969).
Extrapolation of this finding to the
field of cancer chemotherapy suggests
that the frequenev of administration of
certain drugs may be too high, and that
less frequent drug administration, or more
frequent alteration of the nature of the
chemotherapeutic agent, could lead to a
slowing down of the development of
resistance oftumours to chemotherapeutic
agents.
The work reported in this paper was
undertaken duringthetenure ofaResearch
Training Fellowship awarded to B. Szende
by the International Agency for Research
on1 Cancer.
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